- Home
- BCLI vs ABTS Comparison
BCLI vs ABTS Comparison
Compare BCLI & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- ABTS
- Stock Information
- Founded
- BCLI 2000
- ABTS 2010
- Country
- BCLI United States
- ABTS Hong Kong
- Employees
- BCLI N/A
- ABTS N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- ABTS Computer Software: Programming Data Processing
- Sector
- BCLI Health Care
- ABTS Technology
- Exchange
- BCLI Nasdaq
- ABTS Nasdaq
- Market Cap
- BCLI 9.9M
- ABTS 15.9M
- IPO Year
- BCLI N/A
- ABTS N/A
- Fundamental
- Price
- BCLI $1.73
- ABTS $0.41
- Analyst Decision
- BCLI Strong Buy
- ABTS
- Analyst Count
- BCLI 1
- ABTS 0
- Target Price
- BCLI $30.00
- ABTS N/A
- AVG Volume (30 Days)
- BCLI 41.1K
- ABTS 44.7K
- Earning Date
- BCLI 03-31-2025
- ABTS 12-31-2024
- Dividend Yield
- BCLI N/A
- ABTS N/A
- EPS Growth
- BCLI N/A
- ABTS N/A
- EPS
- BCLI N/A
- ABTS N/A
- Revenue
- BCLI N/A
- ABTS $5,343,888.00
- Revenue This Year
- BCLI N/A
- ABTS N/A
- Revenue Next Year
- BCLI N/A
- ABTS N/A
- P/E Ratio
- BCLI N/A
- ABTS N/A
- Revenue Growth
- BCLI N/A
- ABTS 3970.67
- 52 Week Low
- BCLI $1.05
- ABTS $0.38
- 52 Week High
- BCLI $11.85
- ABTS $1.06
- Technical
- Relative Strength Index (RSI)
- BCLI 40.62
- ABTS 40.07
- Support Level
- BCLI $1.69
- ABTS $0.40
- Resistance Level
- BCLI $1.93
- ABTS $0.46
- Average True Range (ATR)
- BCLI 0.11
- ABTS 0.04
- MACD
- BCLI -0.00
- ABTS -0.00
- Stochastic Oscillator
- BCLI 16.67
- ABTS 11.00
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.